New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different kind of treatment than the chemotherapy that is a mainstay for these patients. Called daraxonrasib, the drug is designed to block a mutated protein that fuels most cases of pancreatic cancer, one of the deadliest types of cancer. The research was published Sunday in the New England Journal of Medicine and presented at an American Society of Oncology meeting. Maker Revolution Medicines will seek Food and Drug Administration approval.
Andrea Najas found way to improve care for patients with sarcoma in her home county of Ecuador by working with her doctors at Ohio State University James Cancer Center.
(Cleveland Clinic) - Pregnant and battling breast cancer. A woman from Ohio shares the emotional journey she endured as she fought for her lif…
Most people know breast cancer is one of the most common cancers diagnosed in women. What isn't commonly known is that men can get it too, although it is rare. Meet a young man who was shocked to learn a small lump on his chest was much more than an annoyance.
Delphos Resident David Clark knows what it means to protect and serve his country as well as his local community. Being a Delphos Police Officer as well as an army veteran, Clark has faced many challenged in his career. But no training could prepare him for news he would receive from his doctor.
A recent breast cancer study will spare thousands of patients from undergoing unneeded chemotherapy.